Cerebral metastasis during remission after immunotherapy for metastatic urothelial carcinoma: A case report

Central nervous system (CNS) metastasis of urothelial carcinoma (UC) is rare. Immune checkpoint inhibitors, which were developed for the treatment of patients with advanced cancer, have limited efficacy against CNS metastases due to the unique immune microenvironment of the brain. The brain is an im...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwata, Shohei, Niimi, Fusako, Danno, Tetsuya, Honda, Sachi, Azuma, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165701/
https://www.ncbi.nlm.nih.gov/pubmed/34094543
http://dx.doi.org/10.3892/mco.2021.2307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165701/
https://www.ncbi.nlm.nih.gov/pubmed/34094543
http://dx.doi.org/10.3892/mco.2021.2307

Ejemplares similares